Jaguar Health Completes Preferred Stock Conversion, Adding 4.86M Common Shares
JAGX sits 43% above its 52-week low of $2.12.
Summary
Jaguar Health has completed the conversion of its Series O preferred stock into 4.86 million common shares. This event follows a special dividend of Series O preferred shares and results in a new total of 4,857,211 common shares outstanding. Given the company's micro-cap status and implied prior share count of approximately 600,000 shares, this conversion represents significant dilution for existing shareholders. This capital restructuring occurs after the company recently reported a Q1 2026 financial turnaround, which included a $19 million licensing deal and debt reduction.
At the time of this announcement, JAGX was trading at $3.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8M. The 52-week trading range was $2.12 to $97.65. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.